Akathisia and Newer Second ‐Generation Antipsychotic Drugs: A Review of Current Evidence
ConclusionClinicians should consider risk of akathisia when choosing a treatment option and monitor for akathisia in patients beginning therapy with an SGA or following a dose increase of the SGA.
Source: Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - Category: Drugs & Pharmacology Authors: Constance L. Chow,
Nour K. Kadouh,
Jolene R. Bostwick,
Amy M. VandenBerg Tags: REVIEW OF THERAPEUTICS Source Type: research
More News: Bipolar | Clinical Trials | Depression | Drugs & Pharmacology | Dyskinesia | Dystonia | Mania | Schizophrenia | Study | Websites